Trial Profile
Doxazosin alone or versus in combination with celecoxib in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jul 2012
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Doxazosin
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Therapeutic Use
- 20 Jul 2012 New trial record
- 24 May 2012 Results presented at the 107th Annual Meeting of the American Urological Association.